CHAPEL-EN-LE-FRITH, England, January 12, 2011 /PRNewswire/ -- Peakdale Molecular, a leading discovery and research services company, announced today that it has received the CIR accreditation from the French Ministry of Higher Education and Research.
This accreditation recognises Peakdale as an approved provider of research services to companies in France, thereby allowing French pharmaceutical, biotech and technology companies to benefit from significant tax relief on research carried out by Peakdale on their behalf.
Dr. Mick Durrant, Peakdale's Director of Business Development, commented: "We are thrilled to receive this approval from the French Ministry of Higher Education and Research, which will support the development of the Peakdale client base in France. Our French customers will be able to recoup significant R&D costs through this innovative scheme."
For further information concerning the Credit d'Impot sur la Recherche, please visit http://www.enseignementsup-recherche.gouv.fr
About Peakdale Molecular Limited
Peakdale Molecular is based in Chapel-en-le Frith, Derbyshire and has been established as a provider of research services to the pharmaceutical and biotechnology industry since 1992. In state of the art laboratories with over 90 chemists it continues to provide problem solving expertise from discovery to scale up across Europe and the USA. For more information on Peakdale Molecular, please visit http://www.peakdale.co.uk.
CONTACT Dr. Mick Durrant Director of Business Development Telephone: +44-1298-816-700 firstname.lastname@example.org
SOURCE Peakdale Molecular Ltd